Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Scientific Reports|May 14, 2022
TDP-43 regulates cholesterol biosynthesis by inhibiting sterol regulatory element-binding protein 2Naohiro Egawa, Yuishin Izumi, Hidefumi Suzuki, et al.Eclinicalmedicine|December 5, 2022
Safety and tolerability of bosutinib in patients with amyotrophic lateral sclerosis (iDReAM study): A multicentre, open-label, dose-escalation phase 1 trialKeiko Imamura, Yuishin Izumi, Makiko Nagai, et al.BMJ Open|December 5, 2019
Induced pluripotent stem cell-based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis patientsKeiko Imamura, Yuishin Izumi, Haruhiko Banno, et al.BMJ Open|October 26, 2024
Protocol for a phase 2 study of bosutinib for amyotrophic lateral sclerosis using real-world data: induced pluripotent stem cell-based drug repurposing for amyotrophic lateral sclerosis medicine (iDReAM) studyKeiko Imamura, Yuishin Izumi, Naohiro Egawa, et al.Science Translational Medicine|June 7, 2013
Response to comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells"Naohiro Egawa, Shiho Kitaoka, Kayoko Tsukita, et al.Science Translational Medicine|August 3, 2012
Drug screening for ALS using patient-specific induced pluripotent stem cellsNaohiro Egawa, Shiho Kitaoka, Kayoko Tsukita, et al.Cell Stem Cell|February 26, 2013
Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsivenessTakayuki Kondo, Masashi Asai, Kayoko Tsukita, et al.Pageof 4